Last reviewed · How we verify
NCT03780998
Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases
trial testing Life7 in Hemorrhoids in 250 participants. Status unknown.
1 January 2019
Quick facts
| Lead sponsor | SB Istanbul Education and Research Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 1 January 2019 |
| Primary completion | 1 January 2019 |
| Estimated completion | 1 January 2020 |
Drugs / interventions tested
- Life7 — full drug profile →
Conditions studied
- Hemorrhoids — all drugs for Hemorrhoids →
- Anal Fissure — all drugs for Anal Fissure →
- Perianal Fistula — all drugs for Perianal Fistula →
Sponsor
SB Istanbul Education and Research Hospital
Who can join
18 and older, any sex, with Hemorrhoids or Anal Fissure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
New produced and patented sodium pantaborat based gel will be use for treatment of benign perianal diseases (hemooroidal disease, anal fissura anda perianal fistula)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03780998
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hemorrhoids
Currently open trials in the same condition.
- NCT07350460 — PUSHES (Pudendal Block Versus Sacral ESP Hemorrhoidectomy Study) · NA · recruiting
- NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
- NCT05782010 — SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids · NA · recruiting
- NCT05697562 — Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease · NA · recruiting
- NCT03972956 — Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease · recruiting
Other SB Istanbul Education and Research Hospital trials
Trials by the same sponsor.
- NCT07071571 — New Intraoperative Nerve Monitoring Device · NA · not yet recruiting
- NCT06873087 — Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema · Phase 4 · completed
- NCT04940169 — Anterior Cruciate Ligament Reconstruction Made With Hamstring Tendon And Quadriceps Tendon Autografts · NA · completed
- NCT03051308 — University of Wisconsin Solution Versus New Parathyroid Transport Solution for Parathyroid Allotransplantation · NA · unknown
- NCT04230343 — Limits of the Social Benefit Motive Among High-risk Patients: a Field Experiment on Influenza Vaccination Behaviour · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03780998 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SB Istanbul Education and Research Hospital
- Last refreshed: 21 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03780998.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing